1056934-87-2

Basic information

• Product Name: TERT-BUTYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE
• Synonyms: TERT-BUTYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE;6-Boc-4-dichloro-5,6,7,8-...;6-Boc-4-dichloro-5,6,7,8-tetrahydropyrido[4,3-d]pyriMidine;tert-Butyl 4-chloro-7,8-dihydropyrido[4,3-d]pyriMidin-6(5H)-carboxylate;TERT-BUTYL 4-CHLORO-7,8-DIHYDROPYRIDO;tert-butyl 4-chloro-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carboxylate;4-Chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylic acid 1,1-dimethylethyl ester;tert-butyl 4-chloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxylate
• CAS NO: 1056934-87-2
• Molecular Formula: C₁₂H₁₆ClN₃O₂
• Molecular Weight: 269.73
• Product Categories: pyrimidine;Heterocycle-Pyrimidine series
• Mol File: 1056934-87-2.mol

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: TERT-BUTYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE(1056934-87-2)
• EPA Substance Registry System: TERT-BUTYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE(1056934-87-2)

Safety Data

• Hazardous Substances Data: 1056934-87-2(Hazardous Substances Data)

Usage

Uses

Since the specific pharmaceutical uses and properties of TERT-BUTYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE are not provided in the materials, the following uses are speculative based on its chemical structure and typical applications of similar compounds:
Used in Pharmaceutical Industry:
TERT-BUTYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE is used as a potential drug candidate for [specific therapeutic area] due to its unique chemical structure and functional groups that may exhibit biological activity.
Used in Medicinal Chemistry Research:
TERT-BUTYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE is used as a precursor in organic synthesis for the development of new pharmaceutical compounds, leveraging its heterocyclic core and functional groups for further chemical modifications.

Upstream product

• 41276-30-6 C₉H₁₄O₃NC₆H₅ 
• 109229-22-3 6-benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one 

Relevant articles and documents

Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration

The benefit of intravitreal anti-VEGF therapy in treating wet age-related macular degeneration (AMD) is well established. Identification of VEGFR-2 inhibitors with optimal ADME properties for an ocular indication provides opportunities for dosing routes beyond intravitreal injection. We employed a high-throughput in vivo screening strategy with rodent models of choroidal neovascularization and iterative compound design to identify VEGFR-2 inhibitors with potential to benefit wet AMD patients. These compounds demonstrate preferential ocular tissue distribution and efficacy after oral administration while minimizing systemic exposure.